Literature DB >> 11052316

Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers.

N Kim1, S H Lim, K H Lee, S E Choi, H C Jung, I S Song, C Y Kim.   

Abstract

This study was conducted to investigate whether or not the eradication of H. pylori could lead to the regression of intestinal metaplasia (IM) in patients with either duodenal ulcer (DU) or benign gastric ulcer (BGU). The initial antral IM grade was 0.21 in the 72 patients of the H. pylori-eradicated DU group, this decreased to 0.17, 0.14, 0.13, and 0.09 after periods of four weeks, one year, two years, and four years, respectively, but without statistical significance. In the corpus of the DU group, where IM grade was low (0.02), there was no detectable change in IM. The initial antral IM grade of 0.69 in the 41 patients of the H. pylori-eradicated BGU group decreased substantially to 0.61, 0.44, and 0.39 after periods of four weeks and one and two years, respectively, but again without statistical significance. The initial corporal IM grade of the BGU group of 0.27 decreased to 0.20, 0.15, and 0.06 after periods of four weeks and one and two years, again without statistical significance. In contrast, the IM grades of the noneradicated DU group (N = 20) and the BGU group (N = 16) showed nearly no change in the antrum and corpus. Gastritis grades of antrum and corpus in the H. pylori-eradicated DU or BGU group significantly decreased with respect to time (P = 0.0001), but there were no significant changes in the corresponding noneradicated groups. Although there was no statistical significance, IM decreased in the antrum and corpus of the stomach with BGU and in antrum of those with DU over a two to four-year period after H. pylori eradication, suggesting the possible reversibility of IM.

Entities:  

Mesh:

Year:  2000        PMID: 11052316     DOI: 10.1023/a:1005534328511

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  43 in total

1.  Chronic gastritis: a clinico-pathological classification.

Authors:  P Correa
Journal:  Am J Gastroenterol       Date:  1988-05       Impact factor: 10.864

Review 2.  Identifying persons at risk for gastric cancer?

Authors:  S Miehlke; E Bayerdörffer; A Meining; M Stolte; P Malfertheiner
Journal:  Helicobacter       Date:  1997-07       Impact factor: 5.753

3.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

Authors:  T Watanabe; M Tada; H Nagai; S Sasaki; M Nakao
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

4.  Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma.

Authors:  L E Hansson; L Engstrand; O Nyrén; D J Evans; A Lindgren; R Bergström; B Andersson; L Athlin; O Bendtsen; P Tracz
Journal:  Gastroenterology       Date:  1993-10       Impact factor: 22.682

5.  Long-term follow-up of gastric histology after Helicobacter pylori eradication.

Authors:  G M Forbes; J R Warren; M E Glaser; D J Cullen; B J Marshall; B J Collins
Journal:  J Gastroenterol Hepatol       Date:  1996-07       Impact factor: 4.029

6.  Long-term effect of Helicobacter pylori eradication on gastric metaplasia in patients with duodenal ulcer.

Authors:  N Kim; S H Lim; K H Lee; S E Choi
Journal:  J Clin Gastroenterol       Date:  1998-10       Impact factor: 3.062

7.  Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori.

Authors:  E M Witteman; M Mravunac; M J Becx; W P Hopman; J S Verschoor; G N Tytgat; R W de Koning
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

Review 8.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

9.  Levels of nitrite, nitrate, N-nitroso compounds, ascorbic acid and total bile acids in gastric juice of patients with and without precancerous conditions of the stomach.

Authors:  G M Sobala; B Pignatelli; C J Schorah; H Bartsch; M Sanderson; M F Dixon; S Shires; R F King; A T Axon
Journal:  Carcinogenesis       Date:  1991-02       Impact factor: 4.944

10.  Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large.

Authors:  P Sipponen; M Kekki; M Siurala
Journal:  Br J Cancer       Date:  1984-04       Impact factor: 7.640

View more
  5 in total

Review 1.  Eradication of H pylori for the prevention of gastric cancer.

Authors:  Karolin Trautmann; Manfred Stolte; Stephan Miehlke
Journal:  World J Gastroenterol       Date:  2006-08-28       Impact factor: 5.742

2.  No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea.

Authors:  N Kim; S H Lim; K H Lee
Journal:  Dig Dis Sci       Date:  2001-12       Impact factor: 3.199

Review 3.  Helicobacter pylori eradication for gastric cancer prevention.

Authors:  Ting Kin Cheung; Harry H X Xia; Benjamin C Y Wong
Journal:  J Gastroenterol       Date:  2007-01       Impact factor: 7.527

Review 4.  Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer.

Authors:  Yo Han Park; Nayoung Kim
Journal:  J Cancer Prev       Date:  2015-03

5.  Expression of CDX2 in gastric cardia adenocarcinoma and its correlation with H. pylori and cell proliferation.

Authors:  Ying Zhang; Hu Wang; Chao Bi; Yinping Xiao; Zhaoyong Liu
Journal:  Oncotarget       Date:  2016-08-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.